Phitonex

Raleigh, United States Founded: 2017 • Age: 9 yrs Acquired By Thermo Fisher Scientific
Fluorescent labels and instrumentation for biomarkers are developed.
Request Access

About Phitonex

Phitonex is a company based in Raleigh (United States) founded in 2017 by Chris Dwyer, Craig LaBoda, and Alvin Lebeck was acquired by Thermo Fisher Scientific in December 2020.. Phitonex has raised $2 million across 3 funding rounds from investors including Thermo Fisher Scientific. Phitonex offers products and services including NovaFluor Dyes and Antibodies. Phitonex operates in a competitive market with competitors including NuProbe, Nanosphere, Sirigen, ATDBio and Akrotome, among others.

  • Headquarter Raleigh, United States
  • Founders Chris Dwyer, Craig LaBoda, Alvin Lebeck
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2 M (USD)

    in 3 rounds

  • Latest Funding Round
    $2 M (USD), Seed

    Oct 21, 2019

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Phitonex

Phitonex offers a comprehensive portfolio of products and services, including NovaFluor Dyes and Antibodies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Dyes for minimizing cross-laser excitation in flow cytometry.

Conjugated antibodies for flow cytometry panel expansion.

Funding Insights of Phitonex

Phitonex has successfully raised a total of $2M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Seed — $2.0M
  • First Round

    (14 Aug 2017)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2019 Amount Seed - Phitonex Valuation

investors

Nov, 2018 Amount Debt – Conventional - Phitonex Valuation

investors

Aug, 2017 Amount Debt – Conventional - Phitonex Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Phitonex

Phitonex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Electron microscopy services and microanalysis instruments are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Phitonex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Phitonex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Phitonex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Phitonex

Phitonex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, Sirigen, ATDBio and Akrotome, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Sensitive multiplex platforms for QPCR are developed using toehold probes.
domain founded_year HQ Location
Diagnostic tests for personalized medicine targeting infections are provided.
domain founded_year HQ Location
High sensitivity fluorescence detection technologies for diagnostics and life science applications
domain founded_year HQ Location
Developer of oligonucleotides
domain founded_year HQ Location
Probes for molecular imaging of tumor margins are designed.
domain founded_year HQ Location
Provides fluorescent products for PCR, DNA analysis, and cell staining in research.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Phitonex

Frequently Asked Questions about Phitonex

When was Phitonex founded?

Phitonex was founded in 2017.

Where is Phitonex located?

Phitonex is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.

Who is the current CEO of Phitonex?

Alvin Lebeck is the current CEO of Phitonex. They have also founded this company.

Is Phitonex a funded company?

Phitonex is a funded company, having raised a total of $2M across 3 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $30K, raised on Aug 14, 2017.

What does Phitonex do?

Phitonex (a spin-off from Duke University) develops fluorescent labels and instrumentation. Its products include NovaFluors (a suite of ultra-bright labels spanning that are used to determine low-abundance biomarkers), InfiniFluors (to avoid spectral overlap), and InfiniSight (instrumentation to increase the number of simultaneously observable molecular biomarkers). The products have application in drug discovery and diagnostics industry. As of May 2018, the company is seeking seed funding to launch its products in 2019.

Who are the top competitors of Phitonex?

Phitonex's top competitors include NuProbe, Nanosphere and Sirigen.

What products or services does Phitonex offer?

Phitonex offers NovaFluor Dyes and Antibodies.

Who are Phitonex's investors?

Phitonex has 1 investor. Key investors include Thermo Fisher Scientific.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available